Methods and apparatus to increase secretion of endogenous naturetic hormones

• US 8,165,674 B2
• Filed: 03/01/2006
• Issued: 04/24/2012
• Est. Priority Date: 03/02/2005
• Status: Active Grant

• Current Assignee: Backbeat Medical, LLC
• Original Assignee: Backbeat Medical, Inc.
• Inventors: Levin, Howard, Gelfand, Mark
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): SARCIONE, JESSICA LYNN
• Application Number:
  US11/276,461
• Publication Number:
  US 20070299475A1
• Time in Patent Office: 2,246 Days
• Field of Search: 607/9, 607/44
• US Class Current: 607/9
• CPC Class Codes: A61M 2025/102 driven by a solenoid-activated pump
• CPC Class Codes: A61M 25/10 Balloon catheters A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02; inflatable balloons for placing stents or stent-grafts A61F2/958 ; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00
• CPC Class Codes: A61M 25/1018 Balloon inflating or inflation-control devices
• CPC Class Codes: A61M 25/10181 Means for forcing inflation fluid into the balloon
• CPC Class Codes: A61M 25/10184 Means for controlling or monitoring inflation or deflation
• CPC Class Codes: A61M 29/00 Dilators with or without means for introducing media, e.g. remedies instruments for performing visual medical inspections of cavities or tubes of the body A61B1/00
• CPC Class Codes: A61N 1/36117 for treating hypertension
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/37235 Aspects of the external programmer

Abstract

A method and apparatus for treatment of heart failure by increasing secretion of endogenous naturetic hormones ANP and BNP such as by stimulation of the heart atria. Heart pacing is done at an atrial contraction rate that is increased and can be higher than the ventricular contraction rate. Pacing may include mechanical distension of the right atrial appendage. An implantable device is used to periodically cyclically stretch the walls of the appendage with an implanted balloon.

Claims

1. A method for pacing a heart of a patient comprising:

determining the patient is suffering from at least one of hypertension, and excessive retention of fluid and sodium;

during a first pacing period synchronously pacing at least one atria and at least one ventricle of the patient'"'"'s heart;

during a second pacing period, asynchronously pacing the at least one atria of the patient'"'"'s heart at an atrial pacing rate and synchronously pacing the at least one ventricle of the patient'"'"'s heart at a ventricular pacing rate, such that the atrial pacing rate exceeds the ventricular pacing rate;

during the pacing of the second pacing period, stressing, beyond a natural stress condition, a wall of the at least one atria due to the atrial pacing rate, wherein the stressed wall secretes a hormone at an elevated secretion level above a secretion level occurring while a natural atrial rate and a natural ventricular rate are equal;

achieving a beneficial therapeutic effect in the patient by the elevated level of the secreted hormone, wherein the beneficial therapeutic effect includes at least one of;

limiting a degree of vasoconstriction, limiting a degree of sodium retention, increasing urine output, inhibiting a renin-angiotensin system, inhibiting endothelin secretion, inhibiting systemic and renal sympathetic activity, and counteracting effects of at least one of norepinephrine, endothelin, and angiotensin II, and

repeatedly alternating the first pacing period and the second pacing period to pace the patient'"'"'s heart, wherein each alternating second pacing period has a duration of at least ten minutes.

2. The method as in claim 1 including blocking electric conduction from the atrium to the ventricle of the patient'"'"'s heart during the second pacing period.

3. The method as in claim 1 including sensing a sinus rhythm of the patient'"'"'s heart and selectively synchronizing the ventricular pacing rate with said rhythm.

4. The method as in claim 1 wherein the first pacing period is of longer duration than the second pacing period.

5. The method in claim 1 wherein the secreted hormone is at least one of an atrial natriuretic peptide (ANP) and a brain natriuretic peptide (BNP).

6. The method of claim 1 wherein the beneficial therapeutic effect includes a treatment of heart failure.

7. The method of claim 1 wherein the pacing during the first pacing period is artificially induced by pacing device.

8. A method for treating heart disease in a patient having a heart, the method comprising:

determining the patient is suffering from at least one of hypertension, and excessive retention of fluid and sodium;

during a first pacing period synchronously pacing at least one atria and at least one ventricle of the patient'"'"'s heart;

during a second pacing period, pacing the patient'"'"'s heart to cyclically stress walls of the at least one atria of the patient'"'"'s heart and restore the walls of the atria to a substantially pre-stressed condition;

causing the stressed walls to secrete a hormone at an elevated level above a natural secretion level occurring naturally when the patient'"'"'s heart is not paced;

achieving a beneficial therapeutic effect to the patient by the hormone secreted at the elevated level, wherein the beneficial therapeutic effect includes at least one of;

limiting a degree of vasoconstriction, limiting a degree of sodium retention, increasing urine output, inhibiting a renin-angiotensin system, inhibiting endothelin secretion, inhibiting systemic and renal sympathetic activity, and counteracting effects of at least one of norepinephrine, endothelin, and angiotensin II, and

repeatedly alternating the first pacing period and the second pacing period to pace the patient'"'"'s heart, wherein each alternating second pacing period has a duration of at least ten minutes.

9. A method as in claim 8 wherein the pacing of the patient'"'"'s heart during the second pacing period includes pacing the at least one atria of the patient'"'"'s heart at an atrial pacing rate and pacing the at least one ventricle at a ventricular pacing rate, such that the atrial pacing rate and the ventricular pacing rate are cyclically repeated to achieve the beneficial therapeutic effect.

10. A method as in claim 8 further comprising stressing the at least one atria by pacing the at least one atria at an accelerated rate during the second pacing period.

11. The method of claim 8 wherein said stressing includes pacing an atrium of the patient'"'"'s heart to contract atrial muscle at a cyclical rate faster than the ventricular contraction rate of the patient'"'"'s heart.

12. The method of claim 8 wherein the pacing during the first pacing period is artificially induced by pacing device.

13. A method for treating disease in a patient having a heart, the method comprising:

determining the patient is suffering from at least one of hypertension, or excessive retention of fluid and sodium;

during a first pacing period synchronously pacing at least one atria and at least one ventricle of the patient'"'"'s heart;

during a second pacing period, pacing the patient'"'"'s heart to achieve an atrial contraction rate faster than a ventricular contraction rate, and

due to the faster atrial contraction rate, stressing the at least one wall of at least one atria of the patient'"'"'s heart due to the pacing during the second pacing period;

due to the stressing of the at least one wall, inducing a tissue in the at lest one stressed wall to secrete greater amounts of a hormone as compared to a secretion amount of the hormone occurring when said pacing is not applied to the patient'"'"'s heart, and

achieving a beneficial therapeutic effect to the patient due to the secretion of the greater amounts of the hormone, wherein the beneficial therapeutic effect includes at least one of;

limiting a degree of vasoconstriction, limiting a degree of sodium retention, increasing urine output, inhibiting a renin-angiotensin system, inhibiting endothelin secretion, inhibiting systemic and renal sympathetic activity, and counteracting effects of at least one of;

norepinephrine, endothelin, and angiotensin II, and

repeatedly alternating the first pacing period and the second pacing period to pace the patient'"'"'s heart, wherein each alternating second pacing period has a duration of at least ten minutes.

14. The method of claim 13 wherein the pacing of the patient'"'"'s heart during the second pacing period includes pacing an atrium at an atrial pacing rate that is faster than the ventricular contraction rate.

15. The method of claim 13 wherein the pacing of the patient'"'"'s heart during the second pacing period includes pacing a ventricle of the patient'"'"'s heart at a ventricular pacing rate slower than the atrial contraction rate.

16. The method of claim 13 further comprising atrioventricular blocking of atrial electric impulses from reaching a ventricle of the patient'"'"'s heart during the second pacing period.

17. The method of claim 13 further comprising atrioventricular blocking of atrial depolarization from reaching a ventricle of the patient'"'"'s heart and causing ventricular depolarization during the second pacing period.

18. The method of claim 13 wherein the pacing during the first pacing period is artificially induced by pacing device.